vasoactive intestinal peptide ; Rattus norvegicus

1208 Article(s)
Pub. Date
#Total Relationship(s)
1 30617 Effects of adrenergic blocking agents on lipolysis and adenyl cyclase activity induced by vasoactive intestinal polypeptide (VIP). Endocrinol Jpn 1978 Aug 1
2 38409 Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain. Naunyn Schmiedebergs Arch Pharmacol 1979 Apr 9
3 83146 Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain. Biochem Pharmacol 1978 2
4 89971 Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. FEBS Lett 1979 Aug 1 1
5 163779 In vitro interactions of gastrointestinal hormones on cyclic adenosine 3':5'-monophosphate levels and amylase output in the rat pancreas. Gastroenterology 1975 Feb 4
6 195749 [Intestinal vasoactive peptide receptors in enterocytes : specific binding and stimulation of cyclic AMP]. C R Acad Hebd Seances Acad Sci D 1977 Jun 6 1
7 204536 Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat. Gastroenterology 1978 Apr 4
8 214557 Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin-(5--27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal polypeptide. J Med Chem 1978 Nov 4
9 218214 Vasoactive intestinal polypeptide: specific binding to rat brain membranes. Proc Natl Acad Sci U S A 1979 Feb 3
10 222624 Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. Fed Proc 1979 Aug 1
11 223821 Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transport in vivo. Dig Dis Sci 1979 Aug 1
12 510498 A study of vasoactive intestinal polypeptide (VIP) stimulated intestinal fluid secretion in rat and its inhibition by indomethacin. Experientia 1979 Nov 15 3
13 576532 Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay. Acta Endocrinol (Copenh) 1977 Mar 2
14 630399 Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Brain Res 1978 Mar 17 1
15 744101 Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 1978 Aug 10
16 1279450 Peptidergic modulation of G-protein coupled cyclic-AMP accumulation in the rat caudate nucleus. Neuropeptides 1992 Jul 4
17 1280937 The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex. Ann Neurol 1992 Oct 1
18 1284326 Effects of pineal-derived indolic compounds and of certain neuropeptides on the growth processes in the thyroid gland. Thyroidology 1992 Apr 6
19 1289063 Multiple cholinergic differentiation factors are present in footpad extracts: comparison with known cholinergic factors. Development 1992 Nov 1
20 1310685 Evidence for the formation of a functional complex between vasoactive intestinal peptide, its receptor, and Gs in lung membranes. J Biol Chem 1992 Feb 15 6
21 1312085 The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem 1992 Mar 15 2
22 1312940 Neuropeptide modulation of muscarinic receptors and function in cerebral cortex of young and senescent rats. Eur J Pharmacol 1992 Feb 13 8
23 1316637 Association of neurotensin receptors with VIP-containing neurons and serotonin-containing axons in the suprachiasmatic nucleus of the rat. Synapse 1992 Apr 1
24 1318039 Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma. Biochem Biophys Res Commun 1992 May 29 1
25 1320983 Vasoactive intestinal polypeptide presynaptically enhances the synaptic transmission in cultured sympathetic neurons. Brain Res 1992 May 8 3
26 1327726 The effect of streptozotocin diabetes on the vasoactive intestinal peptide receptor/effector system in membranes from rat ventral prostate. Endocrinology 1992 Oct 4
27 1327729 Vasoactive intestinal peptide enhances dopamine accumulation in primary cell culture of rat hypothalamus. Endocrinol Jpn 1992 Apr 9
28 1327944 Chronic ethanol intake inhibits both the vasoactive intestinal peptide binding and the associated cyclic AMP production in rat enterocytes. Gen Pharmacol 1992 Jul 7
29 1329741 Organ distribution and characterization of porcine peptides (VIP, CGRP and PHI) that increase cAMP in rat platelets. Biochem Biophys Res Commun 1992 Sep 30 1
30 1330157 GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus. Br J Pharmacol 1992 Sep 2
31 1332138 Demonstration of [125I]VIP binding sites and effects of VIP on cAMP-formation in rat insulinoma (RINm5F and RIN14B) cells. Regul Pept 1992 Jul 2 2
32 1332142 Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide. Regul Pept 1992 Aug 13 3
33 1332181 The lipoxygenase inhibitor nafazatrom inhibits stimulated prolactin secretion in cultured rat lactotrophs (GH4C1 cells). Scand J Clin Lab Invest 1992 Jun 2
34 1332849 Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function. Endocrinology 1992 Dec 2
35 1336189 Molecular properties of the vasoactive intestinal peptide receptor in aorta and other tissues. Peptides 1992 Sep-Oct 6
36 1336298 Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat. Acta Physiol Scand 1992 Nov 5
37 1337377 Differential effect of arachidonic acid on the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelium during sexual maturation. Peptides 1992 Nov-Dec 8
38 1345535 Prolactin and LH release in response to vasoactive intestinal peptide (VIP) administration in spontaneously hypertensive and normotensive rats. Endokrynol Pol 1992 1
39 1352721 Release of vasoactive intestinal polypeptide from the rat gastric fundus. Br J Pharmacol 1992 Mar 1
40 1357580 Somatostatin binding to a fresh rat astrocyte-enriched suspension. Neuropeptides 1992 Sep 1
41 1357581 Somatostatin inhibition of VIP- and isoproterenol-stimulated cyclic AMP production in rat peritoneal macrophages. Neuropeptides 1992 Sep 3
42 1358634 Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7). Eur J Pharmacol 1992 Aug 6 8
43 1364040 Somatostatin inhibits VIP- and forskolin-stimulated cyclic AMP accumulation in enterocytes from rat jejunum. Epithelial Cell Biol 1992 Apr 2
44 1364828 Effects of vasoactive intestinal peptide (VIP) on contractile responses of smooth muscle in rat stomach. Br J Pharmacol 1991 Mar 11
45 1372240 Role of Ca2+ on vasoactive intestinal peptide-induced glucose and adenosine 3',5'-monophosphate production in the isolated perfused rat liver. Endocrinology 1992 Apr 8
46 1372999 Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages. Regul Pept 1992 Feb 18 12
47 1373984 Restoration of diabetes-induced changes in enteric nerves by phorbol 12,13-dibutyrate. Brain Res 1992 Mar 20 4
48 1375285 Vasoactive intestinal polypeptide modulates GABAA receptor function in bipolar cells and ganglion cells of the rat retina. J Neurophysiol 1992 Apr 3
49 1376278 Substance P-, vasoactive intestinal polypeptide-, and cholecystokinin-like immunoreactive fiber projections from the superior colliculus to the dorsal lateral geniculate nucleus in the rat. Exp Brain Res 1992 1
50 1377130 Effect of 3-isobutyl-1-methylxanthine and zaprinast on non-adrenergic non-cholinergic relaxation in the rat gastric fundus. Eur J Pharmacol 1992 Jan 21 4